Table 3.
Summaries of representative articles in sections “MRgHIFU Systems for Delivering High-Intensity Focused Ultrasound” and “Ablation of Peripheral Tissue by Ultrasound to Ameliorate Bone Pain Due To Cancer”
| Article | Model | US parameters | Result/conclusion |
|---|---|---|---|
| Liberman et al. 2009 [33] | In vivo, bone metastases | - Avg. time: 66 min (range 22–162 min) - Avg. sonications: 17.3 (range 8–32) |
- VAS score reduction - Edema at target area - No lasting damage, some calcification of target area |
| Hurwitz et al. 2016 [27] | In vivo, bone metastases | - Avg. sonication time: 83 ± 43 min - Max 65–85 °C |
- NRS score reduction, p < 0.001 |
| Napoli et al. 2017 [29] | In vivo, human Osteoid osteomas |
- 4 ± 1.8 sonications | - VAS score reduction (p = 0.001) - 27/29 patients had pain absence and no intake of NSAIDs |
| Li et a. 2010 [30] | In vivo, human Osteosarcoma, malignant fibrous histiocytoma |
- 70 to 169 W/cm2 - Scanning speed = 1–3 mm/s - Avg. sessions = 2.29 h |
- Pain reduction of p < 0.05 - PET-CT revealed no abnormal radioactivity concentration in tumor areas. |